ARCHIVES

NCI Reorganization Task Forces Near Decisions On New Division’s Makeup; Terry May Be Canidate

This article is from The Cancer Letter archive.

Vol. 05 No. 21 | May 25, 1979

Download PDF Visit The Full Archive

Related Articles

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

December 12, 2003

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Sentinel Lymph Node Excision Has No Impact on Survival

August 26, 2011

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012